30 Participants Needed

Exercise Regimen for Breast Cancer

CC
AL
CT
Overseen ByClinical Trials Contact
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Do I need to stop my current medications to join the trial?

The trial does not specify if you need to stop taking your current medications. However, you cannot be on active chemotherapy to participate.

What data supports the effectiveness of the treatment EXERT-BCH Exercise Regimen for breast cancer survivors?

Research shows that exercise can significantly benefit breast cancer survivors by improving their physical and psychological health. Regular moderate-intensity exercise, combined with resistance training, can enhance aerobic capacity and quality of life, making it an effective part of recovery and ongoing health management.12345

Is the exercise regimen for breast cancer survivors safe?

Exercise programs, including aerobic and resistance training, have been shown to be safe for breast cancer survivors, with no increased risk of lymphedema (swelling due to lymph fluid). These programs can improve muscle strength and overall health without significant adverse effects.13678

How is the EXERT-BCH Exercise Regimen treatment different from other treatments for breast cancer survivors?

The EXERT-BCH Exercise Regimen is unique because it focuses on a structured exercise program specifically designed for breast cancer survivors, incorporating both aerobic and resistance training to improve physical and psychological health. Unlike standard treatments, it emphasizes enjoyable activities, skill development, and social interaction, which are not typically part of conventional cancer care.12689

What is the purpose of this trial?

The purpose of this research study is to evaluate the outcomes of two standard of care group exercise regimens to increase muscle mass in women who have been treated with breast cancer.

Research Team

CC

Colin Champ, MD, CSCS

Principal Investigator

Radiation Oncologist

Eligibility Criteria

This trial is for women aged 20-89 who have been treated for breast cancer, including ductal carcinoma in situ or invasive carcinoma. They must have completed certain treatments like surgery, radiation, chemotherapy, hormonal therapy but can't be on active chemotherapy.

Inclusion Criteria

I have had breast cancer treatment but am not currently on chemotherapy.
You are aged between 20 and 89 years, have a biopsy-confirmed diagnosis of either ductal carcinoma in situ or an invasive type of breast cancer, and you have already received treatment such as surgery, radiation therapy, chemotherapy, immunotherapy or hormonal therapy
I am between 20 and 89 years old.
See 1 more

Exclusion Criteria

My doctor thinks it's unsafe for me to do resistance training due to my severe joint or heart condition.
I am currently receiving chemotherapy for breast cancer.
I cannot safely do group exercise as decided by the study leader.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Fitness Evaluation

Participants undergo a fitness evaluation to customize the exercise program

1 week
1 visit (in-person)

Exercise Program

Participants engage in a monitored group exercise regimen to improve muscle mass

12 weeks
Approximately 36 visits (in-person)

Follow-up

Participants are monitored for changes in muscle and fat mass after the exercise program

4 weeks

Treatment Details

Interventions

  • EXERT-BCH Exercise Regimen
Trial Overview The study compares two exercise regimens to increase muscle mass after breast cancer treatment. One follows the American College of Sports Medicine guidelines and the other varies repetitions per set (6-12-25).
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Experimental Arm / EOC GuidelinesExperimental Treatment1 Intervention
The experimental group will use a regimen that is often used by strength and conditioning coaches to maximize hypertrophy, and is part of the standard regimens at the Exercise Oncology Center (EOC)
Group II: Control Arm / ACSM GuidelinesExperimental Treatment1 Intervention
The control group will follow resistance training guidelines from the American College of Sports Medicine (ACSM) with the goal of promoting hypertrophy

Find a Clinic Near You

Who Is Running the Clinical Trial?

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Lead Sponsor

Trials
52
Recruited
13,000+

Findings from Research

Exercise significantly benefits breast cancer survivors, with recommendations for moderate-intensity aerobic activity 3 to 5 days a week for 20 to 60 minutes, along with resistance training.
Psychological health improves with enjoyable exercise that includes social interaction and skill development, while modifications may be needed for conditions like fatigue or lymphedema.
Exercise for breast cancer survivors: research evidence and clinical guidelines.Courneya, KS., Mackey, JR., McKenzie, DC.[2010]
A community-based exercise program over 16 weeks significantly improved aerobic capacity (measured as VO2peak) and physical function in breast cancer survivors, with both groups showing notable enhancements in their exercise performance.
Breast cancer survivors improved their peak cycling power more than control participants, indicating that tailored community exercise interventions can effectively support recovery and fitness in this population, although the improvements may not match those seen in controlled laboratory settings.
Impact of community-based exercise program participation on aerobic capacity in women with and without breast cancer.Lee, JT., Wagoner, CW., Sullivan, SA., et al.[2021]
An 8-month exercise intervention for women with newly diagnosed breast cancer significantly improved overall survival, with only 5.3% deaths in the exercise group compared to 11.5% in the usual care group after a median follow-up of 8.3 years.
The exercise program also showed a trend towards better disease-free survival, particularly benefiting younger women and those with more advanced disease, suggesting that tailored exercise interventions can enhance outcomes for breast cancer patients.
Exercise following breast cancer: exploratory survival analyses of two randomised, controlled trials.Hayes, SC., Steele, ML., Spence, RR., et al.[2018]

References

Exercise for breast cancer survivors: research evidence and clinical guidelines. [2010]
Impact of community-based exercise program participation on aerobic capacity in women with and without breast cancer. [2021]
Exercise following breast cancer: exploratory survival analyses of two randomised, controlled trials. [2018]
Benefits of 24 versus 12 weeks of exercise and wellness programming for women undergoing treatment for breast cancer. [2018]
Exercise parameters in the management of breast cancer: a systematic review of randomized controlled trials. [2022]
The Cardiac Rehabilitation Model Improves Fitness, Quality of Life, and Depression in Breast Cancer Survivors. [2019]
A Community-Based Exercise and Support Group Program in African-American Breast Cancer Survivors (ABCs). [2021]
Chronic Effects of Resistance Training in Breast Cancer Survivors. [2018]
Effects of resistance exercise in women with or at risk for breast cancer-related lymphedema. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security